- Home
- GDO vs FBIO Comparison
GDO vs FBIO Comparison
Compare GDO & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GDO | FBIO |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.2M | 90.7M |
| IPO Year | 2009 | 2011 |
Fundamental Metrics
Financial Performance| Metric | GDO | FBIO |
|---|---|---|
| Price | $10.05 | $2.63 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 36.4K | ★ 510.7K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | N/A | ★ $63,262,000.00 |
| Revenue This Year | N/A | $55.22 |
| Revenue Next Year | N/A | $40.55 |
| P/E Ratio | ★ N/A | $0.95 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $10.07 | $2.18 |
| 52 Week High | $12.15 | $4.53 |
Technical Indicators
Market Signals| Indicator | GDO | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 23.18 | 38.40 |
| Support Level | N/A | $2.55 |
| Resistance Level | $10.86 | $3.02 |
| Average True Range (ATR) | 0.04 | 0.10 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 2.21 | 3.79 |
Price Performance
Historical ComparisonAbout GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.